GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Novyra Pharmachem Ltd

Novyra Pharmachem Board Meeting to Approve Q2 FY27 Unaudited Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 23 Oct 2026, 06:09 PM IST  ·  BSE ID: 3740bda2-5374-4869-b3ae-455c0c555e41
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has announced a board meeting on November 2, 2026, to approve its financial results for July to September 2026.
🤖 AI Summary
  • Board of Directors meeting for Novyra Pharmachem Ltd scheduled for November 2, 2026.
  • Meeting agenda includes considering and approving Unaudited Financial Results for Q2 FY27.
  • Unaudited results cover the second quarter period ending September 30, 2026.
  • Auditor's Limited Review Report will also be considered during the Board Meeting.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation of a Board Meeting.
👤
Who Is Affected
All shareholders of Novyra Pharmachem Ltd are affected by the upcoming financial results, which will provide insight into the company's performance.
🔍
Management Signal
The scheduling of the Board Meeting demonstrates management's adherence to regulatory requirements for disclosing quarterly financial results by November 2, 2026.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Unaudited Financial Results — check for actual Q2 FY27 performance.
Auditor's Limited Review Report — examine for any significant observations.
Any 'other business' decisions — review for additional material outcomes.
LOW RISK This filing is a routine regulatory announcement of an upcoming event, presenting minimal immediate risk.
💡 Investor Takeaway
Novyra Pharmachem Ltd's Board Meeting on November 2, 2026, will consider Unaudited Financial Results for the second quarter ended September 30, 2026. This intimation sets the timeline for the release of the company's Q2 FY27 performance data.
📅 Company Track Record
Novyra Pharmachem Limited was formerly known as Bansisons Tea Industries Limited. This is the first public filing found for Novyra Pharmachem Ltd, indicating limited historical public data.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Novyra Pharmachem Ltd's Board Meeting scheduled?
The Board Meeting of Novyra Pharmachem Ltd is scheduled to be held on Monday, November 2, 2026.
What financial results will be considered at the Board Meeting?
The Board will consider and approve the Unaudited Financial Results for the second quarter ended on September 30, 2026.
What else is on the agenda for Novyra Pharmachem Ltd's Board Meeting?
In addition to the financial results, the Board will also consider the Auditor's Limited Review Report and any other business with the permission of the Chairman.
What is the previous name of Novyra Pharmachem Limited?
Novyra Pharmachem Limited was formerly known as Bansisons Tea Industries Limited.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.